Comerica Bank grew its stake in Omnicell, Inc. (NASDAQ:OMCL) by 3.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 76,632 shares of the company’s stock after purchasing an additional 2,306 shares during the quarter. Comerica Bank owned about 0.20% of Omnicell worth $3,659,000 at the end of the most recent reporting period.
Several other hedge funds also recently bought and sold shares of OMCL. Turner Investments LLC bought a new stake in shares of Omnicell in the 2nd quarter valued at $181,000. Flinton Capital Management LLC increased its position in shares of Omnicell by 74.6% in the 2nd quarter. Flinton Capital Management LLC now owns 4,216 shares of the company’s stock valued at $182,000 after buying an additional 1,802 shares in the last quarter. Riverhead Capital Management LLC increased its holdings in Omnicell by 76.3% during the 2nd quarter. Riverhead Capital Management LLC now owns 4,230 shares of the company’s stock worth $182,000 after purchasing an additional 1,830 shares in the last quarter. Sei Investments Co. increased its holdings in Omnicell by 36.4% during the 2nd quarter. Sei Investments Co. now owns 4,652 shares of the company’s stock worth $200,000 after purchasing an additional 1,242 shares in the last quarter. Finally, Pinebridge Investments L.P. increased its holdings in Omnicell by 1.6% during the 2nd quarter. Pinebridge Investments L.P. now owns 4,896 shares of the company’s stock worth $211,000 after purchasing an additional 76 shares in the last quarter. 99.84% of the stock is currently owned by institutional investors.
OMCL has been the subject of a number of research reports. Cantor Fitzgerald increased their target price on Omnicell to $58.00 and gave the stock an “overweight” rating in a report on Friday, October 27th. Zacks Investment Research cut Omnicell from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 1st. Oppenheimer reiterated a “buy” rating and set a $55.00 target price on shares of Omnicell in a report on Thursday, October 19th. Benchmark raised their price objective on Omnicell from $55.00 to $67.00 and gave the company a “buy” rating in a report on Tuesday, September 5th. Finally, Craig Hallum restated a “buy” rating and issued a $62.00 price objective (up previously from $52.00) on shares of Omnicell in a report on Monday, October 30th. One analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $54.86.
Shares of Omnicell, Inc. (NASDAQ:OMCL) opened at $51.00 on Wednesday. Omnicell, Inc. has a one year low of $31.85 and a one year high of $55.40. The company has a quick ratio of 1.08, a current ratio of 1.53 and a debt-to-equity ratio of 0.38.
Omnicell (NASDAQ:OMCL) last issued its earnings results on Thursday, October 26th. The company reported $0.42 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.42. The business had revenue of $186.78 million during the quarter, compared to the consensus estimate of $192.45 million. Omnicell had a negative net margin of 0.51% and a negative return on equity of 0.79%. Omnicell’s revenue was up 5.7% on a year-over-year basis. During the same period last year, the business posted $0.40 EPS. sell-side analysts expect that Omnicell, Inc. will post 0.12 EPS for the current fiscal year.
In other news, EVP Robin Gene Seim sold 9,780 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $48.97, for a total transaction of $478,926.60. Following the transaction, the executive vice president now directly owns 55,896 shares of the company’s stock, valued at $2,737,227.12. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter J. Kuipers sold 3,532 shares of Omnicell stock in a transaction that occurred on Monday, October 2nd. The shares were sold at an average price of $50.96, for a total transaction of $179,990.72. Following the completion of the transaction, the vice president now directly owns 40,714 shares in the company, valued at $2,074,785.44. The disclosure for this sale can be found here. Insiders have sold 38,944 shares of company stock valued at $1,889,592 over the last 90 days. Company insiders own 3.77% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Comerica Bank Boosts Holdings in Omnicell, Inc. (OMCL)” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://ledgergazette.com/2017/12/06/comerica-bank-boosts-stake-in-omnicell-inc-omcl.html.
Omnicell Company Profile
Omnicell, Inc provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence.
Receive News & Ratings for Omnicell Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omnicell Inc. and related companies with MarketBeat.com's FREE daily email newsletter.